|
|
|
|
| MUTATION | |
IVS-II-5 (G->C) | |
| |
| AMINO ACID REPLACEMENT | |
None | |
| TYPE OF BETA-THAL | |
beta+ (severe) | |
| MECHANISM | |
The G->C mutation greatly reduces the efficiency of splicing at the normal 5' site of the IVS-II (see G->T at IVS-I-5) | |
| IDENTIFICATION | |
Amplification of the beta-globin gene; sequencing; dot-blot analysis with allele specific probes | |
| HEMATOLOGY IN HETEROZYGOTE(S) | |
The mother is the likely beta-thal heterozygote: Hb 11.5 g/dl; Hb A2 4.1%; Hb F 1.8% | |
| HEMATOLOGY IN HOMOZYGOTE(S) | |
Not reported | |
| OCCURRENCE | |
In a Chinese family from Guangxi Province, P.R. China | |
| HAPLOTYPE | |
Not reported | |
| FOUND IN COMBINATION WITH ABNORMAL HB(S) | |
Not reported | |
| FOUND IN COMBINATION WITH BETA-THAL ALLELE(S) | |
Found in three Chinese patients together with the codons 41/42 (-TTCT) frameshift: Hb 5.0-6.7 g/dl; Hb A2 6.2, 7.9, 9.1%; Hb F 11.2-12.3%; patients were transfused | |
| OTHER INFORMATION | |
There is a possibility of Hb E being present in the blood used for transfusion explaining the high Hb A2 levels in the compound heterozygotes | |